The immune cells of this subset of patients can be activated to pronounced IL-2 production resulting Nap-specific expansion of CD4+ and CD8+ T cells which probably is a prerequisite for optimal Nap induced anti-tumour effects. The gene discussed is IL2; the disease is neoplasm.